These findings indicate that SMAD pathway activation is essential for TGF-β1-induced PAI-1 expression, and Lrg1-mediated p38 activation may enhance the SMAD pathway and subsequent PAI-1 expression upon TGF-β1 stimulation, accelerating glomerulosclerosis and fibrosis. Here, LRG1 is linked to glomerulosclerosis.